AAP
ANGO icon

Ardsley Advisory Partners’s AngioDynamics ANGO Stock Holding History

Ardsley Advisory Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-30,000
Closed -$412K – 186
2014
Q3 		$412K Buy
+30,000
New +$428K 0.05% 132

Other funds holding ANGO

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ardsley Advisory Partners's ANGO Position: Q4 2014 in Review

Ardsley Advisory Partners sold out of AngioDynamics (ANGO) in Q4 2014, closing a stake of 30,000 shares — an estimated $412K sold.

Ardsley Advisory Partners first reported a position in ANGO in Q3 2014 and held it in 1 quarter. The position peaked at $412K in Q3 2014. 132 funds tracked by Wall St. Rank hold ANGO as of Q4 2014.

  • Ardsley Advisory Partners reported no remaining AngioDynamics position as of Q4 2014 after selling out during the quarter.
  • Ardsley Advisory Partners sold 30,000 AngioDynamics shares in Q4 2014, an estimated $412K.
  • Ardsley Advisory Partners first reported a position in AngioDynamics in Q3 2014 and held it in 1 quarter.
  • Ardsley Advisory Partners's AngioDynamics position peaked at $412K in Q3 2014.
  • 132 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2014.

Based on Ardsley Advisory Partners's 13F filing for Q4 2014, filed 17 Feb 2015.